The primary cell infected during acute HIV neuropathogenesis is the monocyte-derived macrophage. We have demonstrated that there is activation of the BBB (blood-brain barrier) during acute viral infection and at terminal AIDS. However, it has never been determined if there is a requirement for the virus to be carried through the BBB or how these Trojan horses would be induced to cross the BBB. We added SIVmac251-infected (SIV is simian immunodeficiency virus) mononuclear cells (and their supernatants) to the luminal or abluminal compartment of our BBB model. There was activation of both sides of the BBB model, only if viral-infected cells were added to the luminal compartment, as opposed to the addition of cell-free supernatants. This suggests that cell-associated virus is essential for the activation of the BBB. This, in turn, would be expected to lead to further infiltration of cells capable of viral infection. VCAM-1 (vascular cell adhesion molecule 1) staining revealed, for the first time, that there is an absolute requirement for virally infected cells, and not just the presence of virus for the activation of the BBB.
Introduction
Neurological disease is a common complication of AIDS. The clinical syndrome, referred to as AIDS dementia complex, is mirrored in the SIV (simiam immunodeficiency virus)-macaque model of AIDS, and is characterized histologically by perivascular accumulations of macrophages and multinucleated giant cells containing SIV. The SIV-infected macaque is thus the best available model for HIV-associated neuropathology [1] . Leucocyte adhesion to and trafficking across endothelial cells depends on a sequential activation of receptors on the surface of both cell types [2] [3] [4] . The sequential expression of endothelial adhesion molecules and chemoattractants in the central nervous system during HIV infection has not been determined.
As HIV proteins, such as Tat and Nef, are chemotactic for monocytes [5] and lymphocytes [6] respectively, a positive feedback would be anticipated where more and more PBMCs (peripheral blood mononuclear cells) would be recruited to areas of brain containing infected cells. Much of the neuropathological findings of HIV and SIV infection concern infiltrating monocytes and macrophages. Within 14 days, there is evidence of increased monocyte trafficking through the brain of SIV-infected macaques [7, 8] . This suggests that there is an increased chemotactic gradient for these cells to follow.
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We have chosen an in vitro model using autologous MBECs (microvascular brain endothelial cells) grown to confluency on a 3 µm barrier before the addition of astrocytes to the basal surface of the filter. The barrier model is then grown in culture for 48 h to allow the establishment of astrocyte foot processes and tight junctions between MBECs [9] . Using this model, we have examined the very earliest of events in SIV neuroinvasion.
Methods

Cell culture
The in vitro BBB (blood-brain barrier) model was constructed as described previously [9] . In brief, MBECs were cultured as described previously [10] . Fresh frontal cortex was obtained at necropsy. Meninges and blood vessels were removed with sterile forceps and the tissue finely diced. Astrocytes were cultured as described elsewhere [9] . Microglia are removed 1 week after plating by agitation. Each cell type is checked at first passage for purity [astrocytes for GFAP (glial fibrillary acidic protein) and MBECs for glut-1 and CD31], and only cultures >95% pure are used for further studies. At passages 3 and 4, MBECs were seeded at a density of 10 6 /ml on to 3 µm PET filter inserts (24 well; Falcon, Franklin Lakes, NJ, U.S.A.) precoated with 50 µg/ml fibronectin (Sigma, St. Louis, MO, U.S.A.) in 2% gelatin solution. After 5 days in culture, monolayers were checked for confluence by staining with haematoxylin and eosin by standard techniques. Astrocytes, at a density of 10 5 /ml, were seeded on to the lower layer of the filter by inverting the entire multiwell dish. Astrocytes were allowed to adhere for 2 h in a humidified atmosphere before reversion of the dish and addition of MBEC medium to the upper well, and astrocyte medium to the lower well.
In vitro modelling and confocal analyses
SIVmac251-infected or control mononuclear cells were added to the apical surface of the BBB assemblies [11] . After 2 days in culture, the assemblies were washed and prepared for confocal analyses. To control for cell associated from cellfree factors, we also added cell-free culture supernatants from SIVmac251-infected and control mononuclear cells. The filter assemblies were fixed in 4% (w/v) paraformaldehyde and processed for immunocytochemistry. Primary antibody was diluted with PBS containing 1% BSA, incubated at room temperature (20
• C) for 2 h, then washed, and secondary antibody (conjugated with AlexaFluor 488 or 568; Molecular Probes, Eugene, OR, U.S.A.) was applied for 45 min. Controls consisted of substitution of the primary antibody by an equivalent or greater concentration of an isotypematched antibody or normal rabbit serum (for Glut-1). Cellsurface markers [glut-1 and VCAM-1 (vascular cell adhesion molecule 1)] were stained for before permeabilizing with PBS containing Triton X-100 and staining of astrocytes with GFAP preconjugated to cy-3 (results not shown, for clarity). Images were captured for confocal microscopy using a Leica TCS confocal microscope (Leica Microsystems, Exton, PA, U.S.A.) (see Table 1 ).
Results and discussion
These studies were undertaken to discern the events taking place during SIV neuroinvasion. We were interested in how monocytes (some of which may act as Trojan horses) cross the BBB and what effects crossing the barrier have on the component cells of the barrier. Until now, however, it has never been known what has caused the initial infected cell to cross the BBB.
Under normal, resting conditions, the in vivo BBB expresses glut-1, with minimal VCAM-1 expression. This is mirrored in our in vitro model. With terminal SIV disease, we and others have shown that there is a reversal of this staining with decreased glut-1 [12] and increased expression of VCAM-1 [13, 14] .
We used confocal microscopy, and analysed the images using the x-z axis. The resting barrier model has expression of glut-1 (green) on the endothelial cells, with limited expression of VCAM-1 (red), almost exclusively on the endothelial component ( Figure 1A ). As VCAM-1 staining was performed before permeabilization, only VCAM-1 that was functionally expressed on the outer surface of cells, and not that which was contained within vesicles was stained. Addition of SIVinfected cells to the abluminal compartment (or supernatants from SIV-infected cells) induced activation of astrocytes on the lower surface of the barrier, as determined by VCAM-1 staining and confocal microscopy ( Figures 1B and 1C  respectively) . Addition of supernatant from virus-infected cells to the abluminal compartment induced activation of both the endothelial cells and the astrocytes ( Figure 1C) . The presence of viral-infected cells in the lower compartment led to activation of both sides of the barrier, as assessed by VCAM-1 staining ( Figure 1D ). However, if SIV-infected cells are added to the luminal compartment, there is activation of both sides of the barrier model as well as diminished glut-1 expression on the endothelial cells, suggesting loss of endothelial integrity, as anticipated [12] (Figure 1E) .
Thus, to achieve activation of both sides of the barrier, it is necessary to have SIV-infected cells cross the barrier. This could, in part, explain why there is only limited, or restricted, VCAM-1 expression on the endothelial cells of the brain, even when there is high viral load as there is a requirement for SIV-infected cells in addition to virus in plasma to induce high levels of expression of VCAM-1 on astrocytes as well as endothelial cells.
Combined, the results presented here demonstrate that (i) we have a functional model for SIV neuroinvasion and concomitant activation, (ii) viral entry may be a relatively passive process with mononuclear cells constitutively crossing the BBB and (iii) activation of the BBB is probably a multistep process. This will probably begin with minimal activation occurring with viral elements activating the outer layer and increased activation only occurring if the cells that migrate through the BBB are infected with virus.
